Results 201 to 210 of about 9,669,605 (361)
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Life cycle and techno-economic assessment of a solar-biogas hybrid dryer for banana drying. [PDF]
Shigella O +4 more
europepmc +1 more source
Life Cycle Assessment and Material Flow Analysis Research on Electronic Waste in Asia: Trends, Gaps, and Insights [PDF]
Iva Yenis Septiariva, Sapta Suhardono
openalex +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Apicortin defines the <i>Plasmodium</i> apical conoid body but is dispensable for the parasite life cycle. [PDF]
Zeeshan M +7 more
europepmc +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Life Cycle Assessment of the Construction and Demolition Waste Recovery Process. [PDF]
Malinowski M +5 more
europepmc +1 more source
Life cycle assessment of wastewater treatment in developing countries: A review
Alejandro Gallego‐Schmid +1 more
openalex +2 more sources
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source

